John Engel

Lead equity analyst, Stansberry Innovations Report

John Engel is the lead equity analyst for Stansberry Innovations Report, a monthly advisory that shows subscribers how to invest safely in the next technology revolutions. He also works on Prosperity Investor, a monthly newsletter that explores opportunities in the health care sector. Prior to joining Stansberry Research, John worked as a research scientist in a drug-discovery lab, where he spent years developing novel therapeutics.

John holds a Master of Science from Johns Hopkins University. He also has real-world experience working at both a biotech startup and large pharmaceutical companies.

Recent episodes featuring John Engel

Episode #365 | June 10, 2024

A New Government Act Could Disrupt the Biotech Industry